ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION WITH ACUTE CORONARY SYNDROME AFTER PERCUTANEOUS CORONARY INTERVENTION. REVIEW.
Introduction. The review is devoted to the issues of antithrombotic combinations in patients with atrial fibrillation (AF) who underwent percutaneous coronary intervention (PCI) and stenting.
Objective: To analyze the main literature and clinical recommendations on the efficacy and safety of antithrombotic combinations in patients with AF who have undergone PCI and stenting.
Search strategy. The search for scientific publications was carried out in the search engines PubMed, Web of Science, Google Scholar, in the electronic scientific libraries eLibrary, CyberLeninka. The search depth is 15 years (2006-2021). Search for information on the efficacy and safety of antithrombotic combinations in patients with AF who have undergone PCI and stenting.
Results. There are currently a lot of studies comparing the use of oral anticoagulants (OAC) in patients with AF after PCI. With the appearance of the results of large randomized trials, the recommendations for antithrombotic therapy in this category of patients have been updated. We aim to analyze the currently available literature on the problem of TAT and DAT in patients with AF and acute coronary syndrome (ACS), and provide data on the risks and benefits.
Conclusions. A review of the current literature on antithrombotic therapy in patients with AF who have undergone PCI and subsequent coronary artery stenting shows that the preferred regimen is double antithrombotic therapy (DAT) consisting of a P2Y12 inhibitor in combination with UAC, and triple antithrombotic therapy (TAT) exposes them to an increased risk of bleeding. Decisions regarding specific agents and duration of treatment should be based on thrombotic risk, bleeding risk and patient preferences.
Number of Views: 259
Category of articles:
Reviews
Bibliography link
Kassymova A.A, Mansurova J.A., Karazhanova L.K., Zhunuspekova A.S. Antithrombotic therapy in patients with atrial fibrillation with acute coronary syndrome after percutaneous coronary intervention. Review // Nauka i Zdravookhranenie [Science &Healthcare]. 2022, (Vol.24) 6, pp.143-151. doi 10.34689/SH.2022.24.6.019Related publications:
ANALYSIS OF ANTIBIOTIC PRESCRIBING PRACTICES IN PRIMARY HEALTH CARE SETTINGS. PART
GENETIC SUSCEPTIBILITY TO RADIATION-RELATED DISEASES: A REVIEW OF CURRENT LITERATURE
ТЕНДЕНЦИИ ЗАБОЛЕВАЕМОСТИ ИНФЕКЦИОННОГО ЭНДОКАРДИТА ПОСЛЕ ОБНОВЛЕНИЯ МЕЖДУНАРОДНЫХ РУКОВОДСТВУЮЩИХ ПРИНЦИПОВ. ОБЗОР ЛИТЕРАТУРЫ
СРАВНЕНИЕ МЕТОДОВ МОДЕЛИРОВАНИЯ РЕЦЕССИИ ДЕСНЫ НА ЛАБОРАТОРНЫХ ЖИВОТНЫХ
THE ROLE OF ESSENTIAL AND TOXIC TRACE ELEMENTS IN THE DEVELOPMENT OF KIDNEY STONE DISEASE. LITERATURE REVIEW